158 related articles for article (PubMed ID: 6280730)
41. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
Lugnier C; Gauthier C; Le Bec A; Soustre H
Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036
[TBL] [Abstract][Full Text] [Related]
42. Analysis of the relationship between pharmacological inhibition of cyclic nucleotide phosphodiesterase and relaxation of canine tracheal smooth muscle.
Polson JB; Krzanowski JJ; Anderson WH; Fitzpatrick DF; Hwang DP; Szentivanyi A
Biochem Pharmacol; 1979 Apr; 28(8):1391-5. PubMed ID: 87201
[No Abstract] [Full Text] [Related]
43. Effect of inhibitors of cyclic nucleotide phosphodiesterases on electrical and contractile activity of smooth muscle cells.
Kovalev IV; Popov AG; Baskakov MB; Minochenko IL; Kilin AA; Borodin YL; Anfinogenova YD; Kapilevich LV; Medvedev MA
Bull Exp Biol Med; 2002 Jan; 133(1):38-40. PubMed ID: 12170302
[TBL] [Abstract][Full Text] [Related]
44. Pig skin epidermal calmodulin: effect on calmodulin deficient phosphodiesterase.
Iizuka H; Ishizawa H; Koizumi H; Aoyagi T; Miura Y
J Invest Dermatol; 1982 Mar; 78(3):230-3. PubMed ID: 6276475
[TBL] [Abstract][Full Text] [Related]
45. Ontogeny of cyclic AMP and cyclic GMP phosphodiesterase activities and of calmodulin levels in guinea pig ureter.
Cho YH; Wheeler MA; Weiss RM
J Urol; 1988 May; 139(5):1095-8. PubMed ID: 2834569
[TBL] [Abstract][Full Text] [Related]
46. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
47. Characterization of a calmodulin-dependent high-affinity cyclic AMP and cyclic GMP phosphodiesterase from male mouse germ cells.
Geremia R; Rossi P; Mocini D; Pezzotti R; Conti M
Biochem J; 1984 Feb; 217(3):693-700. PubMed ID: 6324744
[TBL] [Abstract][Full Text] [Related]
48. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
49. [Ca2+-calmodulin-activated cyclic nucleotide phosphodiesterase from the rabbit myometrium].
Osipenko AA; Prishchepa LA; Kurskiĭ MD
Ukr Biokhim Zh (1978); 1986; 58(4):26-31. PubMed ID: 3016961
[TBL] [Abstract][Full Text] [Related]
50. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
Medvedeva MV
Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
[TBL] [Abstract][Full Text] [Related]
51. Increase in calcium sensitivity of cardiac myofibrils contributes to the cardiotonic action of sulmazole.
van Meel JC; Zimmermann R; Diederen W; Erdman E; Mrwa U
Biochem Pharmacol; 1988 Jan; 37(2):213-20. PubMed ID: 2829914
[TBL] [Abstract][Full Text] [Related]
52. Effect of trifluoperazine on cyclic nucleotide phosphodiesterase activity in crude homogenates of bovine adrenal medulla.
Crimaldi AA; Kuo IC; Coffee CJ
Ann N Y Acad Sci; 1980; 356():367-8. PubMed ID: 6263155
[No Abstract] [Full Text] [Related]
53. Calmodulin and cyclic nucleotide-phosphodiesterase activities in rat mammary gland during the lactogenic cycle.
Pizarro M; Puente J; Sapag-Hagar M
FEBS Lett; 1981 Dec; 136(1):127-30. PubMed ID: 6274696
[No Abstract] [Full Text] [Related]
54. Inhibition of human lung cyclic nucleotide phosphodiesterases by proxyphylline, theophylline and their metabolites.
Selvig K; Bjerve KS
Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):250-2. PubMed ID: 6291318
[TBL] [Abstract][Full Text] [Related]
55. RMI 12330A, an inhibitor of cyclic nucleotide phosphodiesterases and adenylate cyclase in kidney preparations.
Hunt NH; Evans T
Biochim Biophys Acta; 1980 Jun; 613(2):499-506. PubMed ID: 6256001
[TBL] [Abstract][Full Text] [Related]
56. Different sensitivites of cyclic nucleotide phosphodiesterases of rat brain and lung to inhibition by new anti-allergic chromones [proceedings].
Saeed SA; Butt NM; Spicer JW; Warren BT
Biochem Soc Trans; 1979 Dec; 7(6):1308-10. PubMed ID: 231533
[No Abstract] [Full Text] [Related]
57. Effects of Ca2+ and calmodulin on cyclic nucleotide metabolism in neurosecretosomes isolated from ox neurohypophyses.
Dartt DA; Torp-Pedersen C; Thorn NA
Brain Res; 1981 Jan; 204(1):121-8. PubMed ID: 6113872
[TBL] [Abstract][Full Text] [Related]
58. 1-(4-Aminobenzyl)-and 1-(4-aminophenyl)isoquinoline derivatives: synthesis and evaluation as potential irreversible cyclic nucleotide phosphodiesterase inhibitors.
Walker KA; Boots MR; Stubbins JF; Rogers ME; Davis CW
J Med Chem; 1983 Feb; 26(2):174-81. PubMed ID: 6298424
[TBL] [Abstract][Full Text] [Related]
59. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
60. Inhibition by 2- or/and 8-substituted adenosine derivatives of adenosine deaminase and calmodulin-dependent phosphodiesterase.
Sasaki Y; Ono Y
Nucleic Acids Symp Ser; 1980; (8):s163-6. PubMed ID: 6265879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
